...
首页> 外文期刊>Clinical Pediatrics >Cold preparation use in young children after FDA warnings: Do concerns still exist?
【24h】

Cold preparation use in young children after FDA warnings: Do concerns still exist?

机译:FDA警告后在幼儿中使用冷制剂:是否仍然存在担忧?

获取原文
获取原文并翻译 | 示例
           

摘要

Objective. To characterize the use and delivery of cough and cold medicines in children younger than 6 presenting to an inner-city pediatric emergency department (PED) following 2007 FDA warnings. Methods. A cross-sectional observational study was performed using a convenience sampling of PED patients during the fall of 2010. Caregivers were presented with 6 commonly used cough medicine preparations and were asked to demonstrate if and how they would administer these to their children. Results. In all, 65 patients and their caregivers consented and participated in the study. During the demonstration, 82% (53/65) stated that they would treat with cough or cold medicines, and 72% (38/53) incorrectly dosed the medication they desired to give. Conclusions. Despite current recommendations, cough and cold medicines are still used in children younger than 6 years of age. A significant portion of caregivers report that they are still unaware of public warnings, potential side effects, and interactions with other medications.
机译:目的。根据2007年FDA警告,向市内小儿急诊科(PED)呈现的6岁以下儿童咳嗽和感冒药的使用和递送特征。方法。一项横断面观察性研究是在2010年秋季使用PED患者的便利样本进行的。向护理人员介绍了6种常用的咳嗽药制剂,并要求他们证明是否以及如何对孩子服用。结果。共有65位患者及其护理人员同意并参加了该研究。在演示过程中,有82%(53/65)的人说他们会用止咳药或感冒药来治疗,而有72%(38/53)的人用药剂量不正确。结论尽管有当前的建议,但对于6岁以下的儿童仍使用止咳药和感冒药。很大一部分护理人员报告说,他们仍然不知道公共警告,潜在的副作用以及与其他药物的相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号